Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chimerin 1 pseudogene (ENSG00000250292) is a genomic locus with sequence similarity to the protein-coding CHN1 (chimerin 1) gene but contains mutations that disrupt its coding potential, such as premature stop codons or frameshifts[1][3]. As a pseudogene, it lacks the ability to produce a functional protein product and does not act as a receptor, enzyme, transporter, or other typical drug target. Pseudogenes can be processed (resulting from retrotransposition) or duplicated (from gene duplication), and while most are transcriptionally inactive, some produce RNA that can participate in regulatory networks—e.g., by sponging microRNAs or acting as ceRNAs[4]. However, there is no specific evidence that chimerin 1 pseudogene has such functions or disease associations. Pseudogenes in general are not considered druggable targets, and this locus is not included in therapeutic targeting strategies or biomarker panels. Summary of key points: - Chimerin 1 pseudogene (ENSG00000250292) is a non-coding, defunct genetic locus related to the CHN1 protein-coding gene[3]. - It is not a valid therapeutic target, and thus has no associated drugs, mechanisms, or safety concerns[1][3][4]. - As a pseudogene, its most likely biological impact is as a source of noncoding RNA with potential—though not documented—regulatory function[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chimerin 1 pseudogene.